<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"mandibular reconstruction":1,
"maxillary reconstruction":1,
"osteocutaneous and fasciocutaneous flaps":1,
"scapular flap":1,
"subscapular vessels":1,
"TBSRTC":1,
"cytology":2,
"fine needle aspiration":1,
"follicular adenoma":1,
"the Bethesda system for reporting thyroid cytopathology":1,
"thyroid carcinoma":3,
"Fluorodeoxyglucose F18":1,
"Incidental findings":2,
"Positron-emission tomography":1,
"Prevalence":1,
"Thyroid gland":1,
"Thyroid neoplasms":2,
"breast cancer":3,
"dynamic jaw mode":1,
"static tomotherapy delivery":1,
"68Ga-DOTA-NOC":1,
"PET/CT":1,
"benign variants":1,
"neuroendocrine tumor (NET)":2,
"TKI":1,
"mRCC":1,
"sorafenib":1,
"sunitinib":1,
"thyroid function":1,
"gene mutation":1,
"immunohistochemistry":2,
"lung adenocarcinoma":2,
"papillary thyroid tumour":1,
"tumour-to-tumour metastasis":1,
"CHEK2":1,
"CHK2":1,
"double primary cancers":1,
"mutation":3,
"thyroid cancer":13,
"FFPE":1,
"cold ischaemic time":1,
"formalin fixation time":1,
"interlaboratory variation":1,
"optimization":1,
"pre-analytical phase":1,
"FNA":1,
"pediatric":1,
"thyroid":8,
"thyroid malignancy":1,
"BENIGN THYROID DISEASE":1,
"REARRANGED DURING TRANSFECTION":1,
"THYROID STIMULATING HORMONE":1,
"Axillary lymph node dissection":1,
"Lymphoscintigraphy":1,
"Methylene blue":1,
"Surgery":1,
"Upper limb lymphedema":1,
"Fas gene":1,
"Papillary thyroid carcinoma":6,
"Single nucleotide polymorphism":1,
"BRAF mutation":1,
"HUMARA":1,
"X-chromosome inactivation pattern":1,
"clonal analysis":1,
"intraglandular metastasis":1,
"multicentric occurrence":1,
"multiple papillary thyroid carcinoma":1,
"biomarkers":1,
"differentiated thyroid cancer":2,
"lenvatinib":1,
"multikinase inhibitor":1,
"phase 2":2,
"radioiodine refractory":1,
"diagnostic accuracy":1,
"fine-needle aspiration biopsy":1,
"histopathology":1,
"thyroid nodule":2,
"ultrasonography":1,
"Autonomous adenoma":1,
"ECM":1,
"cAMP":1,
"miRNA":1,
"BRAF":1,
"fine-needle aspirates":1,
"galectin-3":1,
"indeterminate cytology":1,
"microRNA 221 (miR-221)":1,
"microRNA 222 (miR-222)":1,
"Claudins":1,
"Diagnosis":2,
"Mesothelioma":1,
"Therapeutic target":1,
"ROSE":1,
"ancillary testing":1,
"cell block":1,
"molecular marker":1,
"molecular testing":1,
"rapid on-site evaluation":1,
"Multinodular goiter":1,
"Proliferation":1,
"Proteomics":2,
"TTF1":1,
"Thyroid cytology":1,
"Thyroidectomy":2,
"Outcome":1,
"Prognosis":2,
"Risk stratification":1,
"Staging":1,
"Survival":2,
"Cancer presentation":1,
"Cancer prognosticator":1,
"Colon cancer":1,
"Gene rearrangement":1,
"NTRK1":1,
"TRKA":1,
"(131)I-Nimotuzumab":1,
"EGFR":1,
"Head and neck cancer":1,
"Radioimmunotherapy":1,
"Geographical distribution":1,
"Incidence":1,
"Net survival":1,
"Papillary thyroid cancer":1,
"Time trend":1,
"California":1,
"Early-life exposures":1,
"Hygiene hypothesis":1,
"Microbial exposures":1,
"low-grade extraskeletal osteosarcoma":1,
"radiation-associated sarcoma":1,
"C-cell hyperplasia":1,
"MEN2":1,
"Medullary thyroid carcinoma":3,
"Microcarcinoma":1,
"Prophylactic thyroidectomy":1,
"RET mutation":1,
"fine-needle aspiration cytology":1,
"gene expression profiling":1,
"messenger RNA signature":1,
"Cribriform-morular variant":1,
"PIK3CA gene":1,
"Papillary carcinoma":1,
"Chernobyl":1,
"Fukushima":1,
"radiation":1,
"resilience":1,
"Total laryngectomy":1,
"glottic cancer":1,
"hemithyroidectomy":1,
"subglottic lesions":1,
"Dovitinib":1,
"Efficacy":1,
"Safety":1,
"Microscopic node metastasis":1,
"Predictive factor":1,
"Promoter":1,
"SMAD4":1,
"Thyroid tumor":1,
"90Y-microspheres":1,
"99mTc-macroaggregated albumin":1,
"SPECT/CT":1,
"liver neoplasms":1,
"radioembolization":1,
"radiotherapy":1,
"Capsular invasion":1,
"Extrathyroidal extension":1,
"Recurrence":1,
"Strap muscle invasion":1,
"Larynx":1,
"Transoral laser microsurgery":1,
"Voice Handicap Index":1,
"Voice rehabilitation":1,
"incidental thyroid nodule":1,
"incidentaloma":1,
"overdiagnosis":1,
"screening":1,
"Cancer":5,
"Pediatric age":1,
"Anterior neck mass":1,
"Extraosseous chondroma":1,
"Thyroid cartilage":1,
"Apoptosis":2,
"Gemcitabine":1,
"PKM2":1,
"Pancreatic cancer":1,
"p53":2,
"multifocal":1,
"occult":1,
"whole-specimen mapping":1,
"IVF":1,
"assisted reproductive technology":1,
"brain tumor":1,
"neoplasm of the central nervous system":1,
"Extranodal":1,
"Head and neck":1,
"Hodgkin":1,
"Lymphoma":1,
"Mimics":1,
"Non-Hodgkin":1,
"benign thyroid adenoma":1,
"gas chromatography−time-of-flight mass spectrometry":1,
"metabolomics":1,
"ultraperformance liquid chromatography-quadrupole time-of-flight mass spectrometry":1,
"MS-imaging":1,
"mass spectrometry":1,
"anthropometric risk factors":1,
"body surface area":1,
"case-control study":1,
"obesity":1,
"immunocytochemistry":1,
"lung cytopathology":1,
"scoring":1,
"cancer specific survival":1,
"lymph node dissection":1,
"radioactive iodine":1,
"thyroglobulin":1,
"total thyroidectomy":1,
"in-source decay":1,
"intrasurgical diagnosis":1,
"mass spectrometry imaging":1,
"molecular pathology":1,
"pituitary":1,
"Thyroid nodule, Ultrasonography, Validity":1,
"Differentiated thyroid":1,
"Radioiodine therapy":2,
"SCSA":1,
"Semen characteristics":1,
"Sperm DNA fragmentation":1,
"DTC":2,
"TSHR mRNA":1,
"Thyroid mRNA":1,
"qPCR":1,
"composition &amp":1,
"structure marriage":1,
"core−satellite":1,
"double scattering":1,
"enhanced nonlinear scattering":1,
"ultrasound &amp":1,
"MR &amp":1,
"CT trimodal imaging probe":1,
"uniform distribution":1,
"NO-donors":1,
"Non-steroidal anti-inflammatory drugs":1,
"TT cells":1,
"rMTC 6–23 cells":1,
"3′-untranslated region (3′-UTR)":1,
"connexin 43 (Cx43)":1,
"metastasis":1,
"micro ribonucleic acid (miR)-1":1,
"micro ribonucleic acid (miR)-200a":1,
"Epidermal growth factor/EGFR signaling pathway":1,
"Hepatocellular carcinoma":1,
"Migration":1,
"Pyruvate kinase":1,
"Transforming growth factor beta signaling pathway":1,
"Ki67":1,
"Thyroperoxidase":1,
"F341V":1,
"breast":1,
"endometrium":1,
"pten":1,
"uterus":1,
"Papillary thyroid carcinoma (PTC)":1,
"lymph node (LN) metastasis":1,
"prophylactic central lymph node dissection (CLND)":1,
"calcitonin":1,
"medullary thyroid carcinoma (MTC)":1,
"neoplasms":1,
"oncolytic viruses":1,
"viruses":1,
"Electrospray ionization":1,
"Fatty acids":1,
"Ion mobility–mass spectrometry":1,
"Stable isotope labeling":1,
"miR-152":1,
"miR-20b":1,
"miR-34a":1,
"miR-424":1,
"Clinical and genetic characteristics":1,
"Lynch syndrome":1,
"Bone density":1,
"Hypoparathyroidism":1,
"Postmenopause":1,
"Thyroxine":1,
"Alveolar rhabdomyosarcoma":1,
"Chromosomal translocation":1,
"PAX proteins":1,
"Precursor B-cell acute lymphoblastic leukemia":1,
"Tumorigenesis":1,
"chemotherapy":1,
"neoadjuvant":1,
"pathology":1,
"poorly differentiated thyroid carcinoma":1,
"(170 3880) Medical and biological imaging":1,
"(170 4730) Optical pathology":1,
"(170 6935) Tissue characterization":1,
"(180 4315) Nonlinear microscopy":1,
"Fine needle aspiration biopsy":1,
"accuracy":1,
"head mass":1,
"neck mass":1,
"sensitivity":1,
"specificity":1,
"Alveolar soft part sarcoma":1,
"biopsy":1,
"breast metastasis":1,
"CMNa":1,
"histological characteristics":1,
"hyperthyroidism status":1,
"radiographic results":1,
"thyroid paraganglioma":1,
"Breast neoplasm":1,
"Carcinoma":1,
"Medullary":1,
"Neoplasm metastasis":1,
"advanced differentiated thyroid carcinoma":1,
"cyclophosphamide":1,
"sirolimus":1,
"Clonality analysis":1,
"Combined thymic carcinoma":1,
"Type AB thymoma":1,
"Undifferentiated thymic carcinoma":1,
"Germline mutation":1,
"Li-Fraumeni syndrome":1,
"TP53":1,
"Asymptomatic Diseases":1,
"Early Detection of Cancer":1,
"Whole-Body Counting":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2015年8月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
